174 related articles for article (PubMed ID: 9629874)
21. Anticipatory nausea and vomiting in the era of 5-HT3 antiemetics.
Morrow GR; Roscoe JA; Kirshner JJ; Hynes HE; Rosenbluth RJ
Support Care Cancer; 1998 May; 6(3):244-7. PubMed ID: 9629877
[TBL] [Abstract][Full Text] [Related]
22. A multinational study to measure the value that patients with cancer place on improved emesis control following cisplatin chemotherapy.
Dranitsaris G; Leung P; Ciotti R; Ortega A; Spinthouri M; Liaropoulos L; Labianca R; Quadri A
Pharmacoeconomics; 2001; 19(9):955-67. PubMed ID: 11700782
[TBL] [Abstract][Full Text] [Related]
23. Randomized, double-blind, dose-finding study of dexamethasone in preventing acute emesis induced by anthracyclines, carboplatin, or cyclophosphamide:
Italian Group For Antiemetic Research
J Clin Oncol; 2004 Feb; 22(4):725-9. PubMed ID: 14966097
[TBL] [Abstract][Full Text] [Related]
24. Antiemetic effect of ondansetron and dexamethasone in gynecologic malignant patients receiving chemotherapy.
Pradermdee P; Manusirivithaya S; Tangjitgamol S; Thavaramara T; Sukwattana P
J Med Assoc Thai; 2006 Oct; 89 Suppl 4():S29-36. PubMed ID: 17725140
[TBL] [Abstract][Full Text] [Related]
25. Antiemetic strategies for high-dose chemoradiotherapy-induced nausea and vomiting.
Spitzer TR; Grunberg SM; Dicato MA
Support Care Cancer; 1998 May; 6(3):233-6. PubMed ID: 9629875
[TBL] [Abstract][Full Text] [Related]
26. Cancer chemotherapy-induced nausea and vomiting: role of mediators, development of drugs and treatment methods.
Mahesh R; Perumal RV; Pandi PV
Pharmazie; 2005 Feb; 60(2):83-96. PubMed ID: 15739895
[TBL] [Abstract][Full Text] [Related]
27. Comparative activity of antiemetic drugs.
Jordan K; Schmoll HJ; Aapro MS
Crit Rev Oncol Hematol; 2007 Feb; 61(2):162-75. PubMed ID: 17208005
[TBL] [Abstract][Full Text] [Related]
28. New directions in managing chemotherapy-related emesis.
Krasnow SH
Oncology (Williston Park); 1991 Sep; 5(9 Suppl):19-24. PubMed ID: 1836346
[TBL] [Abstract][Full Text] [Related]
29. The severity and pattern of emesis following different cytotoxic agents.
Martin M
Oncology; 1996 Jun; 53 Suppl 1():26-31. PubMed ID: 8692547
[TBL] [Abstract][Full Text] [Related]
30. Medroxyprogesterone acetate for refractory emesis in cisplatin-treated patients.
Hata A; Katakami N; Fujita S; Horai A; Takatori K; Ose T; Kitajima N
J Palliat Med; 2012 Oct; 15(10):1158-60. PubMed ID: 22650802
[TBL] [Abstract][Full Text] [Related]
31. Risk-benefit of antiemetics in prevention and treatment of chemotherapy-induced nausea and vomiting.
Herrstedt J
Expert Opin Drug Saf; 2004 May; 3(3):231-48. PubMed ID: 15155151
[TBL] [Abstract][Full Text] [Related]
32. [Region-wide professional practice evaluation with regards to antiemetic prescription into chemotherapy-induced nausea and vomiting].
Tavernier J; Jouannet-Romaszko M; Bertucat H; Marchiset N; Bahadoor M; Chevrier R
Bull Cancer; 2016; 103(7-8):622-31. PubMed ID: 27178880
[TBL] [Abstract][Full Text] [Related]
33. Reviewing current and emerging antiemetics for chemotherapy-induced nausea and vomiting prophylaxis.
Natale JJ
Hosp Pract (1995); 2015; 43(4):226-34. PubMed ID: 26308912
[TBL] [Abstract][Full Text] [Related]
34. Olanzapine for nausea and vomiting.
Licup N
Am J Hosp Palliat Care; 2010 Sep; 27(6):432-4. PubMed ID: 20508243
[TBL] [Abstract][Full Text] [Related]
35. Ondansetron reduces chemotherapy induced nausea and vomiting refractory to standard antiemetics.
Mitchell PL; Evans BD; Allan SG; Forgeson GV; Mak D; Neave L; Humm G; Langley G; Dickson D; Harvey VJ
N Z Med J; 1992 Mar; 105(929):73-5. PubMed ID: 1532054
[TBL] [Abstract][Full Text] [Related]
36. Thalidomide reduces chemotherapy-induced vomiting.
Gourd E
Lancet Oncol; 2017 Oct; 18(10):e570. PubMed ID: 28890296
[No Abstract] [Full Text] [Related]
37. Reduction of cisplatin-induced emesis by a selective neurokinin-1-receptor antagonist. L-754,030 Antiemetic Trials Group.
Navari RM; Reinhardt RR; Gralla RJ; Kris MG; Hesketh PJ; Khojasteh A; Kindler H; Grote TH; Pendergrass K; Grunberg SM; Carides AD; Gertz BJ
N Engl J Med; 1999 Jan; 340(3):190-5. PubMed ID: 9917226
[TBL] [Abstract][Full Text] [Related]
38. Infusion of palonosetron plus dexamethasone for the prevention of chemotherapy-induced nausea and vomiting.
Hajdenberg J; Grote T; Yee L; Arevalo-Araujo R; Latimer LA
J Support Oncol; 2006 Oct; 4(9):467-71. PubMed ID: 17080735
[TBL] [Abstract][Full Text] [Related]
39. Comparison of granisetron, ondansetron, and tropisetron in the prophylaxis of acute nausea and vomiting induced by cisplatin for the treatment of head and neck cancer: a randomized controlled trial.
Mantovani G; Macciò A; Bianchi A; Curreli L; Ghiani M; Proto E; Santona MC
Cancer; 1996 Mar; 77(5):941-8. PubMed ID: 8608488
[TBL] [Abstract][Full Text] [Related]
40. Management of chemotherapy-induced nausea and vomiting.
Tortorice PV; O'Connell MB
Pharmacotherapy; 1990; 10(2):129-45. PubMed ID: 2190193
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
